Skip to main content

Characterization and genome analysis of novel phage vB_EfaP_IME195 infecting Enterococcus faecalis

Virus Genes volume 54, pages 804–811 (2018)Cite this article

Abstract

Enterococcus faecalis is one of the main bacteria in the human and animal intestine but is also classed as an opportunistic pathogen. During normal growth, E. faecalis produces natural antibiotics and is conducive to human health. As ectopic parasites, E. faecalis is capable of causing infective endocarditis, neonatal sepsis, bloodstream infections, bacteremia, and intraabdominal infections. With the incidence of antibiotic resistance reaching crisis point, it is imperative to find alternative treatments for multidrug-resistant infections. Using phage for pathogen control is a promising treatment option to combat bacterial resistance. In this study, a lytic phage, designated vB_EfaP_IME195, was isolated from hospital sewage using a clinical multidrug-resistant Enterococcus faecalis strain as an indicator. The one-step growth curve with the optimal multiplicity of infection of (MOI) 0.01 revealed a latent period of ~ 30 min and a burst size of ~ 120 plaque-forming units (pfu) per cell. Transmission electron microscopy showed that the phage belongs to the family Podoviridae. Phage vB_EfaP_IME195 has a linear, double-stranded DNA genome of 18,607 bp with a G + C content of 33% and 27 coding sequences (GenBank accession no. KT932700). Run-off sequencing experiments showed that the phage has a unique 59-bp inverted repeat sequences at the terminal ends. BLASTn analysis revealed that vB_EfaP_IME195 shares 92% identity (93% genome coverage) with unpublished E. faecalis phage Idefix. This study reported a novel E. faecalis phage with unique genome termini containing inverted repeats. The isolation and characterization of this novel lytic E. faecalis phage provides the basis for the development of new therapeutic agents like phage cocktails for multidrug-resistant E. faecalis infection, and its unique genomic feature would also provide valuable knowledge and insight for further phage genome analysis.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Jett BD, Huycke MM, Gilmore MS (1994) Virulence of enterococci. Clin Microbiol Rev 7:462–478

    CAS  Article  Google Scholar 

  2. Maki DG, Agger WA (1988) Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 67:248–269

    CAS  Article  Google Scholar 

  3. Richards MJ, Edwards JR, Culver DH, Gaynes RP (2000) Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21:510–515

    CAS  Article  Google Scholar 

  4. Saito HE, Harp JR, Fozo EM (2017) Enterococcus faecalis responds to individual exogenous fatty acids independently of saturation or chain length. Appl Environ Microbiol 84:e01633–e01617

    PubMed  PubMed Central  Google Scholar 

  5. Karki S, Houston L, Land G, Bass P, Kehoe R, Borrell S, Watson K, Spelman D, Kennon J, Harrington G (2012) Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resistance Infect Control 1(1):31–31

    Article  Google Scholar 

  6. Klare I, Witte W, Wendt C, Werner G (2012) Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55:1387

    CAS  Article  Google Scholar 

  7. Organization WH (2014) Antimicrobial resistance: global report on surveillance. Australas Med J 7:237

    Google Scholar 

  8. Nilsson AS (2014) Phage therapy–constraints and possibilities. Ups J Med Sci 119:192–198

    Article  Google Scholar 

  9. Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B (2015) Bacteriophages and phage-derived proteins–application approaches. Curr Med Chem 22(14):1757–1773

    CAS  Article  Google Scholar 

  10. Henry M, Lavigne R, Debarbieux L (2013) Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections. Antimicrob Agents Chemother 57:5961–5968

    Article  Google Scholar 

  11. Tsonos J, Oosterik LH, Tuntufye HN, Klumpp J, Butaye P, De GH, Hernalsteens JP, Lavigne R, Goddeeris BM (2014) A cocktail of in vitro efficient phages is not a guarantee for in vivo therapeutic results against avian colibacillosis. Vet Microbiol 171:470–479

    Article  Google Scholar 

  12. Sulakvelidze A, Alavidze Z, Morris JJ (1934) Bacteriophage therapy. Antimicrob Agents Chemother 2:1110–1110

    Google Scholar 

  13. Flaherty JE, Harbaugh BK, Jones JB, Somodi GC, Jackson LE (2001) H-mutant bacteriophages as a potential biocontrol of bacterial blight of geranium. Hortscience 36:98–100

    Google Scholar 

  14. Guenther S, Huwyler D, Richard S, Loessner MJ (2009) Virulent bacteriophage for efficient biocontrol of listeria monocytogenes in ready-to-eat foods. Appl Environ Microbiol 75:93–100

    CAS  Article  Google Scholar 

  15. Sulakvelidze A (2013) Using lytic bacteriophages to eliminate or significantly reduce contamination of food by foodborne bacterial pathogens. J Sci Food Agric 93:3137–3146

    CAS  Article  Google Scholar 

  16. Chen Y, Sun E, Song J, Yang L, Wu B (2018) Complete genome sequence of a novel T7-like bacteriophage from a Pasteurella multocida capsular type A isolate. Curr Microbiol 75:574–579

    CAS  Article  Google Scholar 

  17. Ellis EL, Max D (1939) The growth of bacteriophage. J Gen Physiol 22:365–384

    CAS  Article  Google Scholar 

  18. Xing S, Zhang X, Qiang S, Jian W, Mi Z, Pei G, Yong H, An X, Fu K, Zhou L (2017) Complete genome sequence of a novel, virulent Ahjdlikevirus bacteriophage that infects Enterococcus faecium. Arch Virol 162:1–5

    Article  Google Scholar 

  19. Gan HM, Sieo CC, Tang SGH, Omar AR, Yin WH (2013) The complete genome sequence of EC1-UPM, a novel N4-like bacteriophage that infects Escherichia coli O78:K80. Virol J 10:308–308

    Article  Google Scholar 

  20. Li P, Chen B, Song Z, Song Y, Yang Y, Ma P, Wang H, Ying J, Ren P, Yang L (2012) Bioinformatic analysis of the Acinetobacter baumannii phage AB1 genome. Gene 507:125–134

    CAS  Article  Google Scholar 

  21. Yang X, Wang Q, Liang B, Wu F, Li H, Liu H, Sheng C, Ma Q, Yang C, Xie J (2017) An outbreak of acute respiratory disease caused by a virus associated RNA II gene mutation strain of human adenovirus 7 in China, 2015. PLos ONE 12:e0172519

    Article  Google Scholar 

  22. Jamal M, Hussain T, Das CR, Andleeb S (2015) Isolation and characterization of a Myoviridae MJ1 bacteriophage against multi-drug resistant Escherichia coli 3. Jundishapur J Microbiol 8:e25917

    Article  Google Scholar 

  23. Merabishvili M, Vandenheuvel D, Kropinski AM, Mast J, Vos DD, Verbeken G, Noben JP, Lavigne R, Vaneechoutte M, Pirnay JP (2014) Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii. PLoS ONE 9(8):e104853

    Article  Google Scholar 

  24. Wu S, Zachary E, Wells K, Loccarrillo C (2013) Phage therapy: future inquiries. Postdoc J 1:24

    PubMed  PubMed Central  Google Scholar 

  25. Ciacci N, D’Andrea MM, Marmo P, Dematte E, Amisano F, Pilato VD, Fraziano M, Lupetti P, Rossolini GM, Thaller MC (2018) Characterization of vB_Kpn_F48, a newly discovered lytic bacteriophage for Klebsiella pneumoniae of sequence type 101. Viruses 10(9):482

    Article  Google Scholar 

  26. Chan BK, Abedon ST, Loccarrillo C (2013) Phage cocktails and the future of phage therapy. Future Microbiol 8:769–783

    CAS  Article  Google Scholar 

  27. Gill JJ, Hyman P (2010) Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 11(1):2–14

    CAS  Article  Google Scholar 

  28. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Parys LV (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLos ONE 4:e4944

    Article  Google Scholar 

  29. Li X, Ding P, Han C, Fan H, Wang Y, Mi Z, Feng F, Tong Y (2014) Genome analysis of Enterococcus faecalis bacteriophage IME-EF3 harboring a putative metallo-beta-lactamase gene. Virus Genes 49:145–151

    Article  Google Scholar 

Download references

Funding

This research was supported by a grant from The National Key Research and Development Program of China (2015AA020108, 2016YFC1202705, AWS16J020, and AWS15J006), the National Natural Science Foundation of China (81572045, 81672001, and 81621005), and the State Key Laboratory of Pathogen and Biosecurity (SKLPBS1518).

Author information

Affiliations

  1. School of Public Health, Lanzhou University, Lanzhou, 730000, China

    Ronghuan Wang & Hui Liu

  2. Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China

    Shaozhen Xing

  3. State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China

    Feiyang Zhao, Ping Li, Zhiqiang Mi & Yigang Tong

  4. Academy of Military Medical Sciences, Beijing, 100085, China

    Taoxing Shi

  5. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100071, China

    Yigang Tong

Authors
  1. Ronghuan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaozhen Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Feiyang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhiqiang Mi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Taoxing Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hui Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yigang Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Yigang Tong, Hui Liu, Taoxing Shi, and Zhiqiang Mi conceived and designed the experiments and critically evaluated the manuscript. Ronghuan Wang was responsible for data and sequence analyses and wrote the manuscript. Shaozhen Xing isolated and identified the phage and conducted the biological characterization experiments. Feiyang Zhao conducted the sequencing experiments. Ping LI extracted the phage nucleotide. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Hui Liu or Yigang Tong.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Edited by Detlev H. Kruger.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, R., Xing, S., Zhao, F. et al. Characterization and genome analysis of novel phage vB_EfaP_IME195 infecting Enterococcus faecalis. Virus Genes 54, 804–811 (2018). https://doi.org/10.1007/s11262-018-1608-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11262-018-1608-6

Keywords

  • Enterococcus faecalis
  • Phage
  • Biological characteristics
  • Genome
  • Termini